机译:Archazolid A的V-ATP酶抑制:一种抑制EMT的新策略
Department of Pharmacy Pharmaceutical Biology Ludwig-Maximilians-University Munich Germany.;
Department of Chemistry Center for Nanoscience (CeNS) Center for Integrated Protein Science;
Department of Pharmacy Pharmaceutical Biology Ludwig-Maximilians-University Munich Germany.;
Department of Chemistry Center for Nanoscience (CeNS) Center for Integrated Protein Science;
Department of Pharmacy Pharmaceutical Biology Ludwig-Maximilians-University Munich Germany.;
Helmholtz Institute for Pharmaceutical Research Saarland Helmholtz Centre for Infection Research;
Department of Pharmacy Pharmaceutical Biology Ludwig-Maximilians-University Munich Germany.;
Department of Pharmacy Pharmaceutical Biology Ludwig-Maximilians-University Munich Germany.;
机译:Archazolid A的V-ATP酶抑制:一种抑制EMT的新策略
机译:紫色粘液杆菌第一个羟基化的阿奇唑利德:分离,结构鉴定和V-ATPase抑制。
机译:带有自旋标签抑制剂DCC和Archazolid的V-ATPase的EPR研究:质子易位亚基c的相互作用动力学
机译:智能腐蚀抑制策略:底物,涂层和抑制剂
机译:确定靶向胰腺癌转移和癌症干细胞的新型上皮间质转化抑制剂(EMT)
机译:V-ATPase抑制剂Archazolid A的抗白血病作用
机译:Archazolid的V-ATPase抑制导致溶酶体功能障碍导致导致的组织蛋白酶B活性蛋白体内体内受损